Mibefradil is more effective than verapamil for restoring post-ischemic function of isolated hearts of guinea pigs with acute renal failure

European Journal of Pharmacology

Volumn 488, Issue 1-3, 2004, Pages 137-146

  Kuhar, Cvetka Grašič ^a   Budihna, Metka V ^a   Pleskovič, Ruda Zorc ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Acute renal failure; Heart; Ischemic reperfusion injury; Isolated, guinea pig; Mibefradil; Verapamil

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; GENTAMICIN; LACTATE DEHYDROGENASE; MIBEFRADIL; VERAPAMIL;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; ELECTROCARDIOGRAPHY; GUINEA PIGS; HEART RATE; KIDNEY FAILURE, ACUTE; L-LACTATE DEHYDROGENASE; MALE; MIBEFRADIL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT; VERAPAMIL;

EID: 1642311132     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.013     Document Type: Article

References (28)

1. 2+ channel antagonist. Am. J. Cardiol. 80:1997;4C-11C.
2. Ali B.H., Al-Qarawi A.A., Haroun E.M., Mousa H.M. The effect of treatment with gum Arabic on gentamicin nephrotoxicity in rats: a preliminary study. Ren. Fail. 25:2003;15-20.
3. Al-Majed A.A., Mostafa A.M., Al-Rikabi A.C., Al-Shabanah O.A. Protective effect of oral Arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol. Res. 46:2002;445-451.
4. Bersohn M.M., Shine K.I. Verapamil protection of ischemic isolated rabbit heart: dependence on pretreatment. J. Mol. Cell. Cardiol. 15:1983;659-671.
5. 2+ channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation. J. Pharmacol. Exp. Ther. 227:1996;1517-1526.
6. Budihna V.M., Vesnaver A., Lorbar M. Effect of timing in cytoprotective action of verapamil in ischemic and hypoxic isolated rat heart. Acta Pharm. 45:1995;421-433.
7. 2+ channel antagonist. J. Hypertens. 15(Suppl. 5):1997;S17-S25.
8. Cunha M.A., Schor N. Effect of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells. Ren. Fail. 24:2000;687-690.
9. Dybkaer R. The tortuous road to the adoption of katal for expression of catalytic activity by the General Conference on Weights and Measures. Clin. Chem. 48:2002;586-590.
10. Farkas A., Qureshi A., Curtis M.J. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Br. J. Pharmacol. 128:1999;41-50.
11. Grašič Kuhar C., Budihna V.M. Effects of mibefradil and verapamil on ischemic-reperfusion injury in the hearts of guinea pigs with acute renal failure. Pflügers Arch. Eur. J. Physiol. 440:2000;R141-R142.
12. Halestrap A.P., Kerr P.M., Javadov S., Woodfield K.Y. Elucidating the molecular mechanism of permeability transition pore and its role in reperfusion injury of the heart. Biochim. Biophys. Acta. 1266:1998;79-94.
13. Hermsmeyer K. Role of T channels in cardiovascular function. Cardiology. 89(Suppl. 1):1998;2-9.
14. 2+-channel antagonists reduce contractility in guinea pig cardiac myocytes. J. Cardiovasc. Pharmacol. 32:1998;232-330.
15. Kerins D.M., Robertson R.M., Robertson D. Hardman J.G., Limbird L.E., Gilman A.G. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. 2001;843-870 McGraw-Hill, New York.
16. Kopple J.D., Ding H., Letoha A., Ivanyi B., Pei-Yuan Qing D., Dux L., Wang H.Y., Sonkodi S. Nephrol. Dial. Transplant. 17:2002;2122-2131.
17. Kumar K.V., Shifow A.A., Naidu M.U., Ratnakar K.S. Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats. Life Sci. 66:2000;2603-2611.
18. Lemasters J.J., Nieminen A.L., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta. 1266:1998;177-196.
19. 2+ pools of ischaemic and reperfused myocardium characterised by electron probe. Cardiovasc. Res. 29:1995;85-94.
20. 2+ antagonists in myocardial ischemia. Am. J. Cardiol. 59:1987;75B-83B.
21. Opie L.H., Phil D. Reperfusion injury and its pharmacological modification. Circul. 80:1989;1049-1061.
22. Pfaffendorf M., Mathy M.J., van der Lee R., van Zwieten P.A. Evidence for a sympatholytic effect of mibefradil in the pithed rat preparation. J. Hypertens. 18:2000;203-207.
23. Raine A.E.G., Seymour A.M.L., Roberts A.F.C., Radda G.K., Ledigham J.G.G. Impairment of cardiac function and energetics in experimental renal failure. J. Clin. Invest. 92:1993;2934-2940.
24. Robinson S.C., Bowmer C.J., Yates M.S. Cardiac function in rats with acute renal failure. J. Pharm. Pharmacol. 44:1992;1007-1014.
25. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W.G., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Riemerma R.A., Riva E., Russel C., Sheridan D.J., Winslow E., Woodward B. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc. Res. 22:1988;447-455.
26. Welker N.A., Banken L. Mibefradil pharmacokinetics and pharmacodynamic population analysis. Int. J. Clin. Pharmacol. Res. 18:1998;63-71.
27. Wroblewski F., LaDue J. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. 90:1955;210-215.
28. Yeo K., Kuaka H., Sato K., Karasawa A. The protective effects of KW-3902, a novel adenosine A1-receptor antagonist, against gentamicin-induced acute renal failure in rats. Jpn. J. Pharmacol. 65:1994;167-170.